MAGI3 and breast cancer: For example, in the MDA-MB-231 human breast cancer cell line and in primary human breast tumors, we found that oncogenic truncations of MAGI3 (MAGI3pPA) are caused by premature polyadenylation (pPA) triggered by intronic PAS activation4.